Compare ZYME & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZYME | LCID |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2022 | 2020 |
| Metric | ZYME | LCID |
|---|---|---|
| Price | $22.81 | $6.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $38.90 | $15.71 |
| AVG Volume (30 Days) | 531.8K | ★ 25.5M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $105,965,000.00 | ★ $595,271,000.00 |
| Revenue This Year | $183.10 | $71.67 |
| Revenue Next Year | N/A | $89.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $11.86 | $1.97 |
| 52 Week High | $29.75 | $25.22 |
| Indicator | ZYME | LCID |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 50.83 |
| Support Level | $22.20 | $5.59 |
| Resistance Level | $23.66 | $6.85 |
| Average True Range (ATR) | 0.92 | 0.90 |
| MACD | -0.30 | 0.06 |
| Stochastic Oscillator | 1.07 | 72.09 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.